Results 201 to 210 of about 5,946,577 (342)

Point-of-Care Testing. Christopher P. Price, PhD, FRCPath, and Jocelyn M. Hicks, PhD, FRCPath, eds. Washington, DC: AACC Press, 1999, 580 pp., $79.00. ISBN 1-890883-23-9. [PDF]

, 2001
Jan Lindemans
openalex   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Saved by point of care echo

JACEP Open, 2023
Donald Byars, Kean Feyzeau, Matthew Jones, Jon David Landon, Barry Knapp   +4 more
openaire   +3 more sources

Debating the Future of Point-of-Care Testing [PDF]

, 2001
Robyn Medeiros
openalex   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

Point-of-Care Ultrasound Use in Hemodynamic Assessment. [PDF]

Biomedicines
Noor A, Liu M, Jarman A, Yamanaka T, Kaul M.   +4 more
europepmc   +1 more source

Ninety-Minute Exclusion of Acute Myocardial Infarction By Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I

, 2001
James McCord, Richard M. Nowak, Peter A. McCullough, Craig C. Foreback, Steven Borzak, Glenn Tokarski, Michael C. Tomlanovich, Gordon Jacobsen, W. Douglas Weaver   +8 more
openalex   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

Correlation of Point-of-Care Intestinal Ultrasound With Endoscopic Disease Severity in Crohn's Disease. [PDF]

JGH Open
Nagarajan KV, Krishnamurthy AN, Yelsangikar A, Patil N, Agarwal R, Indi S, Bang A, Reddy S, Bhat V, Bhat N.   +9 more
europepmc   +1 more source

Point-of-Care Testing for Prothrombin Time, but Not Activated Partial Thromboplastin Time, Correlates With Laboratory Methods in Patients Receiving Aprotinin or epsilon-Aminocaproic Acid While Undergoing Cardiac Surgery [PDF]

, 2002
Tak-Shun Choi, Philip E. Greilich, Shi Chen, James S. Wilson, Amy C. Keller, Martin H. Kroll   +5 more
openalex   +1 more source